By activating the transcription of genes involved in glycolysis, angiogenesis, and cell survival, HIF1A orchestrates the adaptation of cancer cell metabolism to low oxygen environments, thereby promoting tumour progression and resistance to therapy. Here, HIF1A is linked to neoplasm.